Head to head: Barclays plc and H&T Group plc

Should you add Barclays plc (LON:BARC) and/or H&T Group plc (LON:HAT) to your portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Barclays (LSE: BARC) and H&T Group (LSE: HAT) both sit in the FTSE’s broad ‘Financials’ sector. However, in many respects they’re very different companies.

Barclays is a FTSE 100 giant, valued at over £27bn, while H&T is listed on AIM and has a market cap of £110m. The retail division of Barclays serves a largely different customer to those who use H&T’s pawnbroking and associated services. And, thanks to its corporate and investment banking and cards and payments businesses, Barclays generates almost half its income from outside the UK, while H&T operates solely in the domestic market.

Share performance of the two companies this year — particularly since the Brexit vote — has also been markedly different. Barclays is trading 12% below its pre-referendum price, and has fallen 25% since the start of the year. H&T has gained 50% year-to-date, with over 30% coming post-referendum.

The Brexit effect

In today’s interim results for the six months to 30 June, H&T reported a 42% rise in pre-tax profit “through a combination of strong operational performance and a rising gold price”. The gold price averaged £852 per troy ounce for the half year compared with £791 in the same period last year. Furthermore, the average for July was £1,017, which bodes well for a strong second half.

The performance of Barclays, of course, like all banks, is linked to the economic cycle. Downgraded economic forecasts and a Bank of England interest rate cut since the Brexit vote aren’t ideal for Barclays, although quantitative easing (of which we have a new round) has previously helped investment banks outperform those focused solely on retail and commercial banking.

Meanwhile, H&T is in many ways a counter-cyclical business. However, it does have to carefully manage the business in phases of falling gold prices, as well as enjoying (as it is at present) the turbo-boost of gold heading north.

We can see, then, why shareholders of Barclays and H&T have experienced such markedly contrasting fortunes this year. But what of current valuations and longer-term prospects?

Two to buy?

Today’s results show H&T’s strong balance sheet. Current assets of £98m dwarf not only current liabilities of £7m, but also total liabilities of £29m. Tangible net asset value (TNAV) of £79m gives a price-to-TNAV of 1.4 at a current share price of 296p, which looks a reasonable valuation to me for a strong and expanding business.

Banks’ balance sheets, of course, are notoriously opaque, and Barclays’ own valuation is further clouded by the rundown of its non-core assets. However, a price-to-TNAV of just 0.6 at a share price of 163p strikes me as providing a substantial margin of safety.

As to earnings, Barclays trades on a current-year forecast price-to-earnings (P/E) ratio of 13.7. That may not scream ‘value’, but analysts expect earnings to advance strongly next year (despite Brexit headwinds) as non-core runs down, bringing the P/E down to just 9.1.

H&T has a current-year forecast P/E of 16, falling to 15.7 next year. I see this as a reasonable rating on the basis of the strength of the business and the potential for the price of gold to remain elevated for some time, leading to earnings upgrades.

In summary, although very different businesses, whose shares have also performed very differently this year, Barclays’ long-term recovery prospects and low valuation and H&T’s thriving business and reasonable valuation lead me to rate both stocks as buys at current levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »